These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Linezolid in the treatment of brain abscess due to Peptostreptococcus. Salin F; Vianello F; Manara R; Morelli E; Cattelan A; Scarin M; Sgarabotto D Scand J Infect Dis; 2006; 38(3):203-5. PubMed ID: 16500781 [TBL] [Abstract][Full Text] [Related]
29. Linezolid and dexamethasone experience in a serious case of listeria rhombencephalitis. Yılmaz PÖ; Mutlu NM; Sertçelik A; Baştuğ A; Doğu C; Kışlak S J Infect Public Health; 2016; 9(5):670-4. PubMed ID: 26860968 [TBL] [Abstract][Full Text] [Related]
30. Brain abscess due to Listeria monocytogenes: first case report in Thailand. Treebupachatsakul P; Srifeungfung S; Chayakulkeeree M J Med Assoc Thai; 2006 Sep; 89(9):1516-20. PubMed ID: 17100394 [TBL] [Abstract][Full Text] [Related]
31. Endocarditis due to vancomycin-resistant Enterococcus raffinosus successfully treated with linezolid: case report and review of literature. Jasovich A; Ganaha MC; Ebi C; García RD; Blanco MA; Lopardo H Rev Argent Microbiol; 2008; 40(4):204-7. PubMed ID: 19213241 [TBL] [Abstract][Full Text] [Related]
32. Listeria monocytogenes rhomboencephalitis with cranial-nerve palsies: a case report. Shaffer DN; Drevets DA; Farr RW W V Med J; 1998; 94(2):80-3. PubMed ID: 9581507 [TBL] [Abstract][Full Text] [Related]
33. Early experience with linezolid for infections in orthopaedics. Harwood PJ; Talbot C; Dimoutsos M; Sunderland G; Shaw D; Wilcox MH; Giannoudis PV Injury; 2006 Sep; 37(9):818-26. PubMed ID: 16620816 [TBL] [Abstract][Full Text] [Related]
34. Linezolid for patients with neutropenia: are bacteriostatic agents appropriate? Rafailidis PI; Kouranos VD; Christodoulou C; Falagas ME Expert Rev Anti Infect Ther; 2009 May; 7(4):415-22. PubMed ID: 19400761 [TBL] [Abstract][Full Text] [Related]
35. Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections. McKinnon PS; Sorensen SV; Liu LZ; Itani KM Ann Pharmacother; 2006 Jun; 40(6):1017-23. PubMed ID: 16720705 [TBL] [Abstract][Full Text] [Related]
36. Diffusion-weighted magnetic resonance imaging in rhombencephalitis due to Listeria monocytogenes. Hatipoglu HG; Gurbuz MO; Sakman B; Yuksel E Acta Radiol; 2007 May; 48(4):464-7. PubMed ID: 17453530 [TBL] [Abstract][Full Text] [Related]
37. A gerbil model for rhombencephalitis due to Listeria monocytogenes. Blanot S; Joly MM; Vilde F; Jaubert F; Clement O; Frija G; Berche P Microb Pathog; 1997 Jul; 23(1):39-48. PubMed ID: 9250779 [TBL] [Abstract][Full Text] [Related]
38. Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection. Seedat J; Zick G; Klare I; Konstabel C; Weiler N; Sahly H Antimicrob Agents Chemother; 2006 Dec; 50(12):4217-9. PubMed ID: 16982791 [TBL] [Abstract][Full Text] [Related]
39. Linezolid for the treatment of adults with bone and joint infections. Falagas ME; Siempos II; Papagelopoulos PJ; Vardakas KZ Int J Antimicrob Agents; 2007 Mar; 29(3):233-9. PubMed ID: 17204407 [TBL] [Abstract][Full Text] [Related]
40. Relationship of linezolid minimum inhibitory concentration and time to bacterial eradication in treatment for methicillin-resistant Staphylococcus aureus infection. Moise PA; Castro RS; Sul C; Forrest A; Sakoulas G Ann Pharmacother; 2008 Apr; 42(4):592-3. PubMed ID: 18349303 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]